16 September 2016Big Pharma

UK pharma industry welcomes £816m investment in health research

The Association of the British Pharmaceutical Industry (ABPI) has welcomed the Department of Health’s new £816 million ($1.1 billion) investment in health research, stating that it is “a signal of the government’s commitment to invest in innovation”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Court denies Regeneron bid to halt copy of blockbuster eye drug

Interview: Klaus Grabinski, UPC Court of Appeal president

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

UK pharma industry welcomes £816m investment in health research

Editor's picks

Editor's picks

More features